MELINDA DELANCEY: Open Payments
NPI 1548201403 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$171 in 10 payments from 7 companies in 2025. Trend: 2023 $71 · 2024 $244 · 2025 $171
Food & beverage: $171
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $46 |
| Novo Nordisk Inc | 2 | $40 |
| ViiV Healthcare Company | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
| Hologic Sales and Service, LLC | 1 | $15 |
Products named: Wegovy, DOVATO, PIFELTRO, CREON, JARDIANCE, APTIMA.
Industry payments across MS — which companies pay providers there.
